Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-10-24 09:01 am Purchase |
2023-10-12 | 13D | Venator Materials PLC VNTRF |
Citadel Advisors LLC | 198,966 25.300% |
198,966 (New Position) |
Filing History |
| 2023-10-16 4:01 pm Purchase |
2023-10-04 | 13G | VistaGen Therapeutics, Inc. VTGN |
Citadel Advisors LLC | 1,593,936 5.700% |
1,593,936 (New Position) |
Filing History |
| 2023-10-13 4:50 pm Purchase |
2023-10-03 | 13G | Allakos Inc. ALLK |
Citadel Advisors LLC | 4,766,929 5.500% |
4,766,929 (New Position) |
Filing History |
| 2023-10-02 4:13 pm Purchase |
2023-09-20 | 13G | Dutch Bros Inc. BROS |
Citadel Advisors LLC | 3,208,873 5.400% |
3,208,873 (New Position) |
Filing History |
| 2023-09-05 4:14 pm Purchase |
2023-08-25 | 13G | Aclaris Therapeutics, Inc. ACRS |
Citadel Advisors LLC | 3,586,764 5.100% |
3,586,764 (New Position) |
Filing History |
| 2023-08-31 4:01 pm Purchase |
2023-08-21 | 13G | Arhaus, Inc. ARHS |
Citadel Advisors LLC | 2,887,707 5.400% |
2,887,707 (New Position) |
Filing History |
| 2023-08-21 4:07 pm Purchase |
2023-08-11 | 13G | Benitec Biopharma Inc. BNTC |
Citadel Advisors LLC | 180,030 6.900% |
180,030 (New Position) |
Filing History |
| 2023-08-11 4:01 pm Purchase |
2023-08-01 | 13G | Expensify, Inc. EXFY |
Citadel Advisors LLC | 2,711,663 4.000% |
2,711,663 (New Position) |
Filing History |
| 2023-07-27 4:01 pm Purchase |
2023-07-17 | 13G | Semper Paratus Acquisition Corporation LGST |
Citadel Advisors LLC | 933,454 5.900% |
933,454 (New Position) |
Filing History |
| 2023-07-10 4:01 pm Purchase |
2023-06-29 | 13G | Janux Therapeutics, Inc. JANX |
Citadel Advisors LLC | 2,126,135 5.100% |
2,126,135 (New Position) |
Filing History |
| 2023-07-03 4:02 pm Purchase |
2023-06-23 | 13G | Nektar Therapeutics NKTR |
Citadel Advisors LLC | 9,729,752 5.100% |
9,729,752 (New Position) |
Filing History |
| 2023-07-03 4:01 pm Purchase |
2023-06-21 | 13G | Clene Inc. CLNN |
Citadel Advisors LLC | 381,220 5.700% |
381,220 (New Position) |
Filing History |
| 2023-06-12 5:23 pm Purchase |
2023-05-31 | 13G | Lyra Therapeutics, Inc. LYRA |
Citadel Advisors LLC | 2,896,535 5.900% |
2,896,535 (New Position) |
Filing History |
| 2023-06-09 4:28 pm Purchase |
2023-05-30 | 13G | Inflection Point Acquisition Corp. II IPXXU |
Citadel Advisors LLC | 1,500,608 6.000% |
1,500,608 (New Position) |
Filing History |
| 2023-06-05 4:25 pm Purchase |
2023-05-25 | 13G | Icosavax, Inc. ICVX |
Citadel Advisors LLC | 2,189,469 5.300% |
2,189,469 (New Position) |
Filing History |
| 2023-05-19 4:06 pm Purchase |
2023-05-09 | 13G | Acelyrin, Inc. SLRN |
Citadel Advisors LLC | 5,963,800 6.100% |
5,963,800 (New Position) |
Filing History |
| 2023-05-19 4:05 pm Purchase |
2023-05-09 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Citadel Advisors LLC | 2,259,741 4.900% |
875,242 (+63.22%) |
Filing History |
| 2023-05-19 4:04 pm Purchase |
2023-05-09 | 13G | Alchemy Investments Acquisition Corp 1 ALCYU |
Citadel Advisors LLC | 663,323 5.500% |
663,323 (New Position) |
Filing History |
| 2023-05-19 09:15 am Purchase |
2023-05-18 | 13G | Coherus BioSciences, Inc. CHRS |
Citadel Advisors LLC | 5,815,074 6.200% |
5,815,074 (New Position) |
Filing History |
| 2023-05-15 4:47 pm Purchase |
2023-05-03 | 13G | Magenta Therapeutics, Inc. MGTA |
Citadel Advisors LLC | 4,087,110 6.700% |
4,087,110 (New Position) |
Filing History |